Details of the Drug Reposition

General Information of This Drug (ID: DMD9U5Q)

Drug Name
IMA 203   DMD9U5Q
Drug Type
Cell therapy

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Solid tumour/cancer DISZR48F 2A00-2F9Z Phase 1 [1]
Hematologic tumour DIS9Y1NR 2B33.Y Phase 1 [1]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of Immatics.